Jason Gerberry, BofA Securities senior large-cap pharma analyst, joins 'Squawk Box' to discuss the 2026 ASCO Annual Meeting, what to expect from the conference, latest cancer treatment announcements, ...
The 2026 ASCO annual meeting featured a bladder cancer session and a presentation by Dr. Dawood Hasan discussing rethinking ...
ASCO 2026 highlights breast cancer care: gene tests help skip chemo, new SERDs and ADCs improve outcomes, ctDNA guides ...
SurvivorNet on MSN
ASCO 2026 – New treatments for ovarian cancer are changing the game and doctors are moving fast
ovarian cancer new treatments ...
An expert highlights phase 3 trial data evaluating darovasertib as targeted therapy for advanced metastatic pancreatic ...
At the 2026 ASCO Annual Meeting, Ajaz Khan, MD, of City of Hope, highlighted several significant developments across breast ...
ASCO is the preeminent cancer conference, bringing every oncology stakeholder to Chicago for a weekend of breakthrough presentations, pertinent health discussions and a bevy of brand activations.
"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.
The decision was made after a third party pointed out to the conference’s organizers that the clinical data and trial data results from a mid-range study in Triple Negative Breast Cancer (TNBC) ...
Plus Therapeutics will present ReSPECT-LM trial results and host a symposium on leptomeningeal metastases at the SNO/ASCO conference. Announcement of the oral presentation of ReSPECT-LM clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results